Drug intelligence / Profile preview

ReBellaXO

Development stage: Unknown
Lead developer: Regen Suppliers
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Intravenous, Intraarticular, Topical, Soft Tissue Injection

Overview

ReBellaXO is an exosome-based regenerative biologic product developed by Regen Suppliers. It is an acellular, lyophilized allograft derived from Wharton's Jelly mesenchymal stem cells obtained from umbilical cord tissue and is described as containing billions of extracellular vesicles per cc. Rather than acting through a single defined pharmaceutical target, the product is intended to deliver a heterogeneous cargo of exosomes containing proteins, messenger RNA, microRNA, and growth factors that may support tissue repair, extracellular matrix remodeling, and regenerative signaling. It is marketed primarily for regenerative and aesthetic uses such as intravenous administration, joint injection, soft tissue procedures, hair restoration, facial rejuvenation, and sexual rejuvenation, with topical cosmetic positioning in North America.

Brand names: ReBellaXO
Other names: ReBellaXO exosome-based regenerative biologic product

Beyond the preview

Go deeper on ReBellaXO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReBellaXO.

Explore the full profile